Acciones LexaGene Holdings Inc.
Acciones
LXXG.Q
CA52886L1031
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01/03/18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24/03/20 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18/06/18 |
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Tom Slezak
BRD | Director/Board Member | - | 12/10/16 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-36,44 % | 9196,96 M | |
-3,29 % | 3122,86 M | |
+19,31 % | 2801,13 M | |
-18,71 % | 2067,92 M | |
-22,03 % | 1590,12 M | |
+64,58 % | 1441,21 M | |
+34,58 % | 830 M | |
-7,42 % | 724 M | |
-25,51 % | 507 M |